VOYA Investment Management’s RAPT Therapeutics RAPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-7,729
Closed -$555K 2893
2024
Q1
$555K Sell
7,729
-248
-3% -$34.5K ﹤0.01% 1962
2023
Q4
$1.59M Sell
7,977
-4,601
-37% -$570K ﹤0.01% 1463
2023
Q3
$1.67M Hold
12,578
﹤0.01% 1404
2023
Q2
$1.88M Buy
12,578
+11,208
+818% +$1.75M ﹤0.01% 1372
2023
Q1
$201K Buy
+1,370
New +$277K ﹤0.01% 2537
2022
Q4
Sell
-1,241
Closed -$239K 2937
2022
Q3
$239K Buy
+1,241
New +$235K ﹤0.01% 2486
2022
Q1
Sell
-14,113
Closed -$4.15M 2735
2021
Q4
$4.15M Sell
14,113
-62
-0.4% -$16.6K 0.01% 908
2021
Q3
$3.52M Sell
14,175
-997
-7% -$264K 0.01% 957
2021
Q2
$3.86M Sell
15,172
-224
-1% -$41.9K 0.01% 955
2021
Q1
$2.73M Sell
15,396
-2,557
-14% -$422K 0.01% 1050
2020
Q4
$2.84M Buy
17,953
+1,897
+12% +$412K 0.01% 999
2020
Q3
$4.13M Buy
+16,056
New +$3.56M 0.01% 799

Other funds holding RAPT

VOYA Investment Management's RAPT Position: Q2 2024 in Review

VOYA Investment Management sold out of RAPT Therapeutics (RAPT) in Q2 2024, closing a stake of 7,729 shares — an estimated $555K sold.

VOYA Investment Management first reported a position in RAPT in Q3 2020 and held it in 12 quarters. The position peaked at $4.15M in Q4 2021. 103 funds tracked by Wall St. Rank hold RAPT as of Q2 2024.

  • VOYA Investment Management reported no remaining RAPT Therapeutics position as of Q2 2024 after selling out during the quarter.
  • VOYA Investment Management sold 7,729 RAPT Therapeutics shares in Q2 2024, an estimated $555K.
  • VOYA Investment Management first reported a position in RAPT Therapeutics in Q3 2020 and held it in 12 quarters.
  • VOYA Investment Management's RAPT Therapeutics position peaked at $4.15M in Q4 2021.
  • 103 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q2 2024.

Based on VOYA Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.